- USD1124889design2026Packaging0 cites
- US12611397utility2026Pharmaceutical Composition of Darolutamide0 cites
- US12583840utility2026Method for the Preparation of Androgen Receptor Antagonists and Intermediates Thereof0 cites
- USD1116808design2026Packaging Box0 cites
- US12558331utility2026Pregabalin Formulations and Use Thereof0 cites
- USD1096399design2025Packaging0 cites
- USD1096400design2025Packaging0 cites
- USD1085870design2025Packaging0 cites
- USD1083618design2025Packaging0 cites
- US12329742utility2025Pharmaceutical Composition of Darolutamide0 cites
- USD1062469design2025Packaging0 cites
- USD1045618design2024Snack Packaging0 cites
- USD1043366design2024Snack Packaging0 cites
- USD1043365design2024Snack Packaging0 cites
- USD1039388design2024Packaging0 cites
- US12030871utility2024Pyran Dervatives as CYP11A1 (cytochrome P450 Monooxygenase 11A1) Inhibitors0 cites
- USD1029632design2024Packaging for Snack Pack0 cites
- US11771675utility2023Use of Levodopa, Carbidopa and Entacapone for Treating Parkinson's Disease0 cites
- USD0986407design2023Inhaler0 cites
- USD0982735design2023Inhaler0 cites
Page 1 of 2Next →